| scholarly article | Q13442814 |
| P50 | author | Benjamin Hotter | Q52897924 |
| P2093 | author name string | Peter Schratzberger | |
| Josef R Patsch | |||
| Wilfried Schgoer | |||
| Sushil K Mahata | |||
| Josef Marksteiner | |||
| Markus Theurl | |||
| Rudolf Kirchmair | |||
| Tobias Tatarczyk | |||
| Margot Egger | |||
| Angela M Djanani | |||
| Silke Frauscher | |||
| Arno G E Beer | |||
| Danijela Vasiljevic | |||
| P2860 | cites work | Antisense knockdown of sphingosine kinase 1 in human macrophages inhibits C5a receptor-dependent signal transduction, Ca2+ signals, enzyme release, cytokine production, and chemotaxis | Q44987448 |
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 104-111 | |
| P577 | publication date | 2008-09-21 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Monocyte migration: a novel effect and signaling pathways of catestatin | |
| P478 | volume | 598 |
| Q37707732 | Abnormalities in endocrine and immune cells are correlated in dextran‑sulfate‑sodium‑induced colitis in rats |
| Q35003241 | Apolipoprotein E isoform-dependent microglia migration |
| Q33574106 | Biological function and clinical relevance of chromogranin A and derived peptides |
| Q36080486 | Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling |
| Q58583898 | Catestatin as a Target for Treatment of Inflammatory Diseases |
| Q24324814 | Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines |
| Q33838302 | Catestatin: a multifunctional peptide from chromogranin A |
| Q37707717 | Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats |
| Q42350284 | Chromogranin A cell density as a diagnostic marker for lymphocytic colitis |
| Q40277440 | Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome |
| Q56373623 | Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors |
| Q47712415 | Chromogranins: from discovery to current times |
| Q55379370 | D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections. |
| Q35053232 | Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra). |
| Q37083066 | Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis |
| Q38622923 | Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease |
| Q47702359 | Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure |
| Q34618925 | Gut hormones: emerging role in immune activation and inflammation. |
| Q39194237 | Mitogen-activated protein kinase phosphatase 1 (MKP-1) in macrophage biology and cardiovascular disease. A redox-regulated master controller of monocyte function and macrophage phenotype |
| Q42496988 | Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin |
| Q36052958 | Plasma Catestatin: A Useful Biomarker for Coronary Collateral Development with Chronic Myocardial Ischemia |
| Q43442071 | Plasma levels and potential roles of catestatin in patients with coronary heart disease |
| Q38896495 | Potential applications of catestatin in cardiovascular diseases |
| Q41487887 | Reactivation of Intestinal Inflammation Is Suppressed by Catestatin in a Murine Model of Colitis via M1 Macrophages and Not the Gut Microbiota. |
| Q37802015 | Reprint of: Catestatin: A multifunctional peptide from chromogranin A |
| Q49579336 | Role of the neuroendocrine antimicrobial peptide catestatin in innate immunity and pain |
| Q47879810 | Secretogranin III: a diabetic retinopathy-selective angiogenic factor. |
| Q41672979 | Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis |
| Q89944305 | Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease |
| Q36840134 | Sex differences matter in the gut: effect on mucosal immune activation and inflammation |
| Q33886596 | Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation |
| Q37181636 | Sphingosine kinase‑1 mediates endotoxemia‑induced hyperinflammation in aged animals |
| Q54645179 | The Neuropeptide Catestatin Acts As a Novel Angiogenic Cytokine via a Basic Fibroblast Growth Factor–Dependent Mechanism |
| Q36666413 | The extended granin family: structure, function, and biomedical implications |
| Q38241244 | The important role of catestatin in cardiac remodeling |
| Q36630692 | Treatment with novel AP-1 and NF-κB inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis |
Search more.